Bio€quity Europe 2025 marks the 25th anniversary of Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs. Organized by BioCentury and EBD Group, this flagship event provides a unique platform to connect CEOs, venture capital investors, and leaders in business development and licensing (BD&L) .
We are proud to announce that our Chief Executive Officer, Fernando Aguirre, will be attending Bio€quity Europe 2025. His participation underscores our commitment to engaging with the forefront of biotech innovation and investment. Fernando’s presence at this milestone event reflects our dedication to fostering strategic partnerships and staying at the cutting edge of industry developments.
This project has been co-funded by the European Union’s Horizon Europe research and innovation programme under grant agreement Nº101161495.
“Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.”
Stay connected
Subscribe to the HAWK Biosystems newsletter and don’t miss any news about our company, our products, events and much more.